{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:54:32Z","timestamp":1781639672340,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China, General Program","award":["82470819"],"award-info":[{"award-number":["82470819"]}]},{"name":"Natural Science Foundation of Guangdong Province, General Program","award":["2414070000044"],"award-info":[{"award-number":["2414070000044"]}]},{"name":"Natural Science Foundation of Guangdong Province, Youth Enhancement Project","award":["2025A1515012617"],"award-info":[{"award-number":["2025A1515012617"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Early postoperative hyponatremia (EPH, days 1\u20133) following pituitary neuroendocrine tumor (PitNET) surgery is a clinically significant complication with poorly defined risk factors. This study was designed to: (1) identify independent risk factors for EPH across all PitNET subtypes; (2) construct and validate a reliable predictive model using clinicopathological variables; and (3) develop a simplified risk scoring system to guide risk-stratified perioperative management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort study analyzed data from 300 adult patients who underwent PitNET surgery (January 2021 \u2013 December 2024) at Nanfang Hospital. Demographics, tumor characteristics (size, Knosp grade, functional type), preoperative conditions, and surgical details were collected. EPH was defined as serum sodium\u2009&lt;\u2009135 mmol\/L within 1\u20133 days postoperatively. Multivariate binary logistic regression with stepwise selection (entry criterion\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.10, removal criterion\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.10) was used to identify independent risk factors and construct the predictive model. Model performance was evaluated by the area under the receiver operating characteristic curve (AUC), calibration plot, Hosmer-Lemeshow test, and bootstrap resampling (1000 iterations) for internal validation. The optimal risk score cutoff was determined by the Youden index. This study followed the STROBE guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      EPH occurred in 70 patients (23.3%). Five independent risk factors were identified: tumor diameter\u2009&gt;\u200925\u00a0mm (OR\u2009=\u20092.85, 95% CI: 1.52\u20135.34,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), Knosp grade\u2009\u2265\u20093 (OR\u2009=\u20093.10, 95% CI: 1.65\u20135.83,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), adrenocorticotropic hormone (ACTH)-secreting tumor (OR\u2009=\u20093.55, 95% CI: 1.41\u20138.94,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007), preoperative hyponatremia (OR\u2009=\u20094.20, 95% CI: 1.81\u20139.74,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and operative duration\u2009&gt;\u2009180\u00a0min (OR\u2009=\u20092.15, 95% CI: 1.13\u20134.08,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019). The predictive model exhibited excellent discriminative ability (AUC\u2009=\u20090.85, 95% CI: 0.75\u20130.87) and adequate calibration (Hosmer-Lemeshow test: \u03c7\u00b2=8.56, df\u2009=\u20098,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.38), with robust performance confirmed by bootstrap validation (AUC\u2009=\u20090.83). A simplified risk scoring system (0\u20136 points) stratified patients into low- (0\u20131 points, EPH incidence 5.0%), medium- (2\u20133 points, 35.0%), and high-risk (\u2265\u20094 points, 82.5%) groups. The optimal cutoff value (3 points) yielded a sensitivity of 78.6% and specificity of 83.9%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tumor size (&gt;\u200925\u00a0mm), invasiveness (Knosp grade\u2009\u2265\u20093), ACTH-secreting subtype, preoperative hyponatremia, and prolonged operative duration (&gt;\u2009180\u00a0min) are independent predictors of EPH. To our knowledge, this is the first comprehensive predictive model and simplified scoring system for EPH across all PitNET subtypes. The validated tool enables accurate preoperative risk stratification, facilitating personalized perioperative monitoring and targeted interventions to reduce EPH-related complications and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-026-02212-2","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:57:48Z","timestamp":1772531868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early postoperative hyponatremia after pituitary adenoma surgery: risk factors, predictive model, and clinical implications"],"prefix":"10.1186","volume":"26","author":[{"given":"Chunmei","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"6","key":"2212_CR1","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s11596-022-2673-6","volume":"42","author":"X Wan","year":"2022","unstructured":"Wan X, Chen J, Wang J, et al. Overview of the 2022 WHO Classification of Pituitary Adenomas\/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives[J]. Curr Med Sci. 2022;42(6):1111\u20138.","journal-title":"Curr Med Sci"},{"issue":"1","key":"2212_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, et al. Overview of the 2022 WHO Classification of Pituitary Tumors[J]. Endocr Pathol. 2022;33(1):6\u201326.","journal-title":"Endocr Pathol"},{"issue":"5","key":"2212_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1507\/endocrj.K10E-352","volume":"58","author":"Y Kinoshita","year":"2011","unstructured":"Kinoshita Y, Tominaga A, Arita K, et al. Post-operative hyponatremia in patients with pituitary adenoma: post-operative management with a uniform treatment protocol[J]. Endocr J. 2011;58(5):373\u20139.","journal-title":"Endocr J"},{"issue":"3","key":"2212_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1227\/neu.0000000000002927","volume":"95","author":"A Binu","year":"2024","unstructured":"Binu A, Hv E, Nair P, et al. Role of Copeptin in Predicting Postoperative Hyponatremia and Hypernatremia in Patients Undergoing Endoscopic Pituitary Adenoma Surgery[J]. Neurosurgery. 2024;95(3):641\u201350.","journal-title":"Neurosurgery"},{"issue":"2","key":"2212_CR5","first-page":"120","volume":"18","author":"T Wei","year":"2003","unstructured":"Wei T, Zuyuan R, Changbao S, et al. Hyponatremia after transspheniodal surgery of pituitary adenoma[J]. Chin Med Sci J. 2003;18(2):120\u20133.","journal-title":"Chin Med Sci J"},{"issue":"4","key":"2212_CR6","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/foc.2004.16.4.10","volume":"16","author":"CD Cole","year":"2004","unstructured":"Cole CD, Gottfried ON, Liu JK, et al. Hyponatremia in the neurosurgical patient: diagnosis and management[J]. Neurosurg Focus. 2004;16(4):E9.","journal-title":"Neurosurg Focus"},{"key":"2212_CR7","unstructured":"Hall WA, Thorell W, Cerebral salt wasting syndrome. 2025 Jun 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan."},{"key":"2212_CR8","doi-asserted-by":"publisher","first-page":"1660531","DOI":"10.3389\/fendo.2025.1660531","volume":"16","author":"X Lu","year":"2025","unstructured":"Lu X, Sun J, Wang Y, et al. Predictors of delayed hyponatremia after endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas[J]. Front Endocrinol (Lausanne). 2025;16:1660531.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2212_CR9","doi-asserted-by":"publisher","first-page":"e28958","DOI":"10.1016\/j.heliyon.2024.e28958","volume":"10","author":"Z Peng","year":"2024","unstructured":"Peng Z, Li X, Wang Y, et al. Gender potentially affects early postoperative hyponatremia in pituitary adenoma: XGBoost-based predictive modeling[J]. Heliyon. 2024;10(7):e28958.","journal-title":"Heliyon"},{"key":"2212_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3171\/2024.12.JNS241384","volume":"143","author":"W Zeng","year":"2025","unstructured":"Zeng W, Prasad A, Emeh A, et al. Predictive factors for early-onset hyponatremia following endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas[J]. J Neurosurg. 2025;143:406\u201312.","journal-title":"J Neurosurg"},{"issue":"11","key":"2212_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2176\/nmc.48.489","volume":"48","author":"JI Lee","year":"2008","unstructured":"Lee JI, Cho WH, Choi BK, et al. Delayed hyponatremia following transsphenoidal surgery for pituitary adenoma[J]. Neurol Med Chir (Tokyo). 2008;48(11):489\u201392.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"4","key":"2212_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00701-019-03818-3","volume":"161","author":"Y Tomita","year":"2019","unstructured":"Tomita Y, Kurozumi K, Inagaki K, et al. Delayed postoperative hyponatremia after endoscopic transsphenoidal surgery for pituitary adenoma[J]. Acta Neurochir (Wien). 2019;161(4):707\u201315.","journal-title":"Acta Neurochir (Wien)"},{"issue":"7","key":"2212_CR13","first-page":"1353","volume":"62","author":"H Yazar","year":"2016","unstructured":"Yazar H, Firat N, Nalbant A. Cushing\u2019s Syndrome Presenting with Hyponatremia[J]. Clin Lab. 2016;62(7):1353\u20135.","journal-title":"Clin Lab"},{"issue":"11","key":"2212_CR14","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.clineuro.2013.08.019","volume":"115","author":"JD Breshears","year":"2013","unstructured":"Breshears JD, Jiang B, Rowland NC, et al. Use of conivaptan for management of hyponatremia following surgery for Cushing\u2019s disease[J]. Clin Neurol Neurosurg. 2013;115(11):2358\u201361.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"2212_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12020-022-03164-y","volume":"78","author":"H Tanaka","year":"2022","unstructured":"Tanaka H, Nishimura F, Nakase K, et al. Impact of surgical factors on delayed hyponatremia in patients with nonfunctioning pituitary adenoma after endonasal endoscopic transsphenoidal procedure[J]. Endocrine. 2022;78(2):354\u201362.","journal-title":"Endocrine"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02212-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02212-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02212-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:17:03Z","timestamp":1781637423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02212-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2212"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02212-2","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Nanfang Hospital (Guangzhou, China). The requirement for informed consent was waived by the Ethics Committee of Nanfang Hospital due to the retrospective nature of the study and the use of de-identified clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}